Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection | Zendy

Silvia Nozza | Zendy; Andrea Poli | Zendy; Marco Ripa | Zendy; Laura Galli | Zendy; Stefania Chiappetta | Zendy; Vincenzo Spagnuolo | Zendy; Cristina Rovelli | Zendy; Adriano Lazzarin | Zendy; Antonella Castagna | Zendy; Giuseppe Tambussi | Zendy

Open Access

Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection

Author(s) -

Silvia Nozza,

Andrea Poli,

Marco Ripa,

Laura Galli,

Stefania Chiappetta,

Vincenzo Spagnuolo,

Cristina Rovelli,

Adriano Lazzarin,

Antonella Castagna,

Giuseppe Tambussi

Publication year - 2016

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkw439

Subject(s) - elvitegravir , cobicistat , emtricitabine , human immunodeficiency virus (hiv) , tenofovir , medicine , pharmacology , virology , antiretroviral therapy , viral load

ical user interface for sequence alignment and phylogenetic tree building. Mol Biol Evol 2010; 27: 221–4. 5 Wirden M, Tubiana R, Fourati S et al. Upgraded Cobas Ampliprep-Cobas Taqman version 2.0 HIV-1 RNA quantification assay versus first version: correction of underestimations. J Clin Microbiol 2011; 49: 2700–2. 6 Mourez T, Delaugerre C, Vray M et al. Comparison of the bioMérieux NucliSENS EasyQ HIV-1 v2.0-HIV-1 RNA quantification assay versus Abbott RealTime HIV-1 and Roche Cobas TaqMan HIV-1 v2.0 on current epidemic HIV-1 variants. J Clin Virol 2015; 71: 76–81.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research